Lotus Pharmaceutical Co Ltd 1795
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- NT$111.50
- Day Range
- NT$100.50–108.50
- 52-Week Range
- NT$100.50–364.76
- Bid/Ask
- NT$101.00 / NT$101.50
- Shares Outstanding
- 266.39M
- Market Cap
- NT$27.04B
- Volume/Avg
- 4M / 1M
Key Statistics
- Price/Earnings (Normalized)
- 13.15
- Price/Sales
- 0.86
- Dividend Yield (Trailing)
- 2.53%
- Dividend Yield (Forward)
- 2.53%
- Dividend Payment Schedule
- Oct
- Total Yield
- 2.53%
Company Profile
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. Along with its subsidiaries, it is engaged in the research and development, manufacturing, and sales of generic and branded pharmaceutical products, as well as consulting services. Its product portfolio comprises biosimilars, generic medicines, branded medicines, and various therapies in its research and development pipeline. The Group offers a differentiated portfolio of pharmaceuticals spanning several therapeutic areas, including oncology and immunology, CNS, women's health, primary care and lifestyle, and nephrology, among others. Geographically, it generates maximum revenue from the United States, and the rest from Taiwan, South Korea, Singapore, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 1,099
- Website
- https://www.lotuspharm.com
Valuation
Metric | 1795 |
|---|---|
Price/Earnings (Normalized) | 13.15 |
Price/Book Value | 1.09 |
Price/Sales | 0.86 |
Price/Cash Flow | 5.24 |
Price/Earnings
1795
Financial Strength
Metric | 1795 |
|---|---|
Quick Ratio | 0.82 |
Current Ratio | 1.33 |
Interest Coverage | 1.66 |
Quick Ratio
1795
Profitability
Metric | 1795 |
|---|---|
Return on Assets (Normalized) | 2.63% |
Return on Equity (Normalized) | 10.43% |
Return on Invested Capital (Normalized) | 8.61% |
Return on Assets
1795
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|vQ^r<^%! | LOCK|d#FW | $70B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|#!ZPL%c | LOCK|?&Y? | $47B | |||
| Haleon PLC ADR HLN | LOCK|#plN&x | LOCK|tzs | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|<KCBTM< | LOCK|<T | $32B | |||
| Viatris Inc VTRS | LOCK|>?#?%SR | LOCK|JmH | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|@h | LOCK|!<J | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|GrnYMN | LOCK|!s | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|n&m!>@G | LOCK|L<z | $3B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|j!p&lD$ | LOCK|?rHZ | $2B | |||
| Perrigo Co PLC PRGO | LOCK|HnphcG | LOCK|#>@ | $2B |